ETC
IMCR icon

Exchange Traded Concepts’s Immunocore IMCR Stock Holding History

Exchange Traded Concepts’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,241
Closed -$126K – 1457
2025
Q1 		$126K Sell
4,241
-834
-16% -$25K ﹤0.01% 1079
2024
Q4 		$150K Hold
5,075
– – ﹤0.01% 1056
2024
Q3 		$158K Buy
5,075
+1,461
+40% +$53.1K ﹤0.01% 1048
2024
Q2 		$122K Sell
3,614
-1,124
-24% -$57.3K ﹤0.01% 930
2024
Q1 		$308K Buy
4,738
+2,082
+78% +$143K 0.01% 789
2023
Q4 		$181K Buy
2,656
+674
+34% +$35K ﹤0.01% 798
2023
Q3 		$103K Sell
1,982
-494
-20% -$29.2K ﹤0.01% 881
2023
Q2 		$148K Buy
+2,476
New +$141K ﹤0.01% 845

Other funds holding IMCR

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Exchange Traded Concepts's IMCR Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Immunocore (IMCR) in Q2 2025, closing a stake of 4,241 shares — an estimated $126K sold.

Exchange Traded Concepts first reported a position in IMCR in Q2 2023 and held it in 8 quarters. The position peaked at $308K in Q1 2024. 133 funds tracked by Wall St. Rank hold IMCR as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Immunocore position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 4,241 Immunocore shares in Q2 2025, an estimated $126K.
  • Exchange Traded Concepts first reported a position in Immunocore in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's Immunocore position peaked at $308K in Q1 2024.
  • 133 funds tracked by Wall St. Rank held Immunocore as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.